InMed Pharmaceuticals Inc (INM)
0.2268
-0.02
(-6.67%)
USD |
NASDAQ |
Nov 05, 16:00
0.2268
0.00 (0.00%)
After-Hours: 19:00
InMed Pharmaceuticals Profit Margin (Quarterly): -151.0% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -151.0% |
| March 31, 2024 | -146.9% |
| December 31, 2023 | -119.2% |
| September 30, 2023 | -281.3% |
| June 30, 2023 | -14.64% |
| March 31, 2023 | -193.2% |
| December 31, 2022 | -447.2% |
| September 30, 2022 | -1.09K% |
| June 30, 2022 | -1.53K% |
| March 31, 2022 | -1.12K% |
| December 31, 2021 | -1.62K% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.62K%
Minimum
Dec 2021
-14.64%
Maximum
Jun 2023
-610.5%
Average
-281.3%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| CeCors Inc | -- |
| Venus Concept Inc | -120.3% |
| Grace Therapeutics Inc | -- |
| Aurinia Pharmaceuticals Inc | 1.26% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.10% |
| Return on Assets | -58.63% |
| Return on Invested Capital | -70.10% |
| Gross Profit Margin (Quarterly) | 36.32% |
| Operating Margin (Quarterly) | -156.6% |
| Return on Net Operating Assets | -174.0% |